Topics

PubMed Journals Articles About "Lung Cancer Research Funding News Magazine Raises Question" RSS

16:57 EST 28th January 2020 | BioPortfolio

Lung Cancer Research Funding News Magazine Raises Question PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Lung Cancer Research Funding News Magazine Raises Question articles that have been published worldwide.

More Information about "Lung Cancer Research Funding News Magazine Raises Question" on BioPortfolio

We have published hundreds of Lung Cancer Research Funding News Magazine Raises Question news stories on BioPortfolio along with dozens of Lung Cancer Research Funding News Magazine Raises Question Clinical Trials and PubMed Articles about Lung Cancer Research Funding News Magazine Raises Question for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lung Cancer Research Funding News Magazine Raises Question Companies in our database. You can also find out about relevant Lung Cancer Research Funding News Magazine Raises Question Drugs and Medications on this site too.

Showing "Lung Cancer Research Funding News Magazine Raises Question" PubMed Articles 1–25 of 42,000+

Comparison of Cancer Burden and Nonprofit Organization Funding Reveals Disparities in Funding Across Cancer Types.

Nonprofit organizations (NPOs) in oncology are vital for patient advocacy and funding research for rare cancers, young investigators, and innovative projects. However, some cancers may be underfunded relative to their burden. This study examined the alignment of cancer burden by histology with NPO funding for each histology.


Effect of digital alteration information and disclaimer labels attached to fashion magazine advertisements on women's body dissatisfaction.

The present study aimed to investigate whether the provision of prior information about digital alteration would enhance the effectiveness of disclaimer labels attached to fashion images in protecting against body dissatisfaction. Participants were 363 female undergraduate students who viewed fashion magazine advertisements with either no label or a digital alteration disclaimer label. Prior to viewing the advertisements, participants read one of three news stories containing digital alteration information ...

A Portfolio Analysis of Autism Research Funding in Australia, 2008-2017.

Autism research funding across the world has disproportionately been invested in biological and genetic research, despite evidence that these topics are not prioritized by community members. We sought to determine whether a similar pattern was evident in Australia's autism research funding landscape between 2008 and 2017, by analysing the nation's portfolio of autism research investments. We also examined whether there was any change in this pattern of funding since the establishment in 2013 of the Cooperat...


Increased risk of coronary heart disease and stroke in lung cancer survivors: A Korean nationwide study of 20,458 patients.

With advances in lung cancer treatments, the number of lung cancer survivors has increased. As cardiovascular diseases (CVD) are some of the major causes of non-cancer deaths, CVD management is an integral part of cancer survivorship care. However, there is sparsity of data on cardiovascular risk in lung cancer survivors who underwent lung cancer surgery. We aimed to compare the incidence of CVD between lung cancer survivors and the general non-cancer population.

Research Agenda of the Oncology Nursing Society: 2019-2022 (Executive Summary).

The Oncology Nursing Society (ONS) is committed to promoting excellence in oncology nursing and quality cancer care. In keeping with this mission, since 2001, ONS has prepared and disseminated a national Research Agenda. The ONS Research Agenda serves to identify gaps in the knowledge base needed to deliver quality cancer nursing care to patients and families, articulate priorities for research, and delineate critical areas for funding consideration by funding agencies. A multimethod, iterative, consensus-b...

Galectin-9 in non-small cell lung cancer.

Lung cancer has the highest incidence and fatality among all cancers. Our research analyzed the expression of galectin-9 on non-small cell lung cancer (NSCLC) tumor cells and tumor infiltrating lymphocytes (TILs).

Correction to: Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer.

In the original publication of the article, the funding information was incorrectly published. The corrected funding statement is given in this correction article.

The Prognosis of Lung Cancer With Different Metastatic Patterns.

Distant organ metastases do not occur at random in lung cancer. A retrospective study was conducted in order to evaluate 1) what kinds of metastatic patterns exist in three different types of lung cancer, and 2) whether metastatic patterns affected prognosis in the different types of lung cancer.

Gender differences in grant and personnel award funding rates at the Canadian Institutes of Health Research based on research content area: A retrospective analysis.

Although women at all career stages are more likely to leave academia than men, early-career women are a particularly high-risk group. Research supports that women are less likely than men to receive research funding; however, whether funding success rates vary based on research content is unknown. We addressed gender differences in funding success rates for applications directed to one or more of 13 institutes, representing research communities, over a 15-year period.

Lung cancer risk and do-it-yourself activities. A neglected risk factor for lung cancer.

The aim of this study was to assess the relationship between do-it-yourself activities entailing the exposure to carcinogenic substances and the risk of lung cancer.

Federal Funding For Research On The Leading Causes Of Death Among Children And Adolescents.

Firearm injuries are the second-leading cause of death for US children and adolescents (ages 1-18). This analysis quantified the federal dollars granted to research for the leading US causes of death for this age group in 2008-17. Several federal data sources were queried. On average, in the study period, $88 million per year was granted to research motor vehicle crashes, the leading cause of death in this age group. Cancer, the third-leading cause of mortality, received $335 million per year. In contras...

Next Generation of Lung Cancer Management.

The most important lung cancer research falls under the hub of personalized medicine. There is an expanding list of lung cancer genotypes that researchers have identified as relevant, and even more importantly, that they have discovered targeted therapies for. In addition, scientists are learning more about predictive markers for immunotherapy that may inform clinicians on how to optimally treat patients. Both targeted therapy and immunotherapy are approved in advanced non-small cell lung cancer and oncolog...

Translation and cultural adaptation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Lung Cancer Module for quality of life assessment in patients with lung cancer in Brazil.

To translate the European Organisation for Research and Treatment of Cancer (EORTC) 29-item Quality of Life Questionnaire-Lung Cancer Module (QLQ-LC29, developed for the assessment of quality of life in patients with lung cancer) to Portuguese, conducting a pilot study of the Portuguese-language version and adapting it for use in Brazil.

"My doctor says the cancer is worse, but i believe in miracles"-When religious belief in miracles diminishes the impact of news of cancer progression on change in prognostic understanding.

News of cancer progression is critical to setting accurate prognostic understanding, which guides patients' treatment decision making. This study examines whether religious belief in miracles modifies the effect of receiving news of cancer progression on change in prognostic understanding.

Prevalence and outcome of central airway obstruction in patients with lung cancer.

Central airway obstruction (CAO) is a life-threatening complication of lung cancer. The prevalence of CAO in lung cancer patients is unknown. We audited CAO burden to inform our local cancer service.

Tissue ACE phenotyping in lung cancer.

Pulmonary vascular endothelium is the main metabolic site for Angiotensin I-Converting Enzyme (ACE)-mediated degradation of several biologically-active peptides (angiotensin I, bradykinin, hemo-regulatory peptide Ac-SDKP). Primary lung cancer growth and lung cancer metastases decrease lung vascularity reflected by dramatic decreases in both lung and serum ACE activity. We performed precise ACE phenotyping in tissues from subjects with lung cancer.

The current and future landscape of radiotherapy for lung cancer.

Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities.

American Indians and Alaska Natives (AI/AN) continue to experience extreme lung cancer health disparities. The state of Minnesota is home to over 70,000 AI/AN, and this population has a 2-fold increase in lung cancer mortality compared to other races within Minnesota. Genetic mutation testing in lung cancer is now a standard of high-quality lung cancer care, and EGFR mutation testing has been recommended for all adenocarcinoma lung cases, regardless of smoking status. However, genetic testing is a controver...

Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer.

Circular RNAs (circRNAs), a large class of non-coding RNAs with covalently closed-loop structures, are abundant, stable, conserved, and have tissue and developmental-stage specificities. The biological functions of circRNAs are varied. Moreover, circRNAs participate in various pathological processes, especially in multiple cancers. Lung cancer is the most frequent malignant tumor worldwide. Many studies have suggested that circRNAs are pivotal in non-small cell lung cancer. This article aims to provide a re...

Diverse resistance mechanisms to the third-generation ALK inhibitor lorlatinib in ALK-rearranged lung cancer.

Lorlatinib is a third-generation ALK tyrosine kinase inhibitor with proven efficacy in patients with ALK-rearranged lung cancer previously treated with first and second-generation ALK inhibitors. Beside compound mutations in the kinase domain, other resistance mechanisms driving lorlatinib resistance remain unknown. We aimed to characterize mechanisms of resistance to lorlatinib occurring in patients with -rearranged lung cancer and design new therapeutic strategies in this setting.

Lung Cancer Detection using Probabilistic Neural Network with modified Crow-Search Algorithm.

Lung cancer is a type of malignancy that occurs most commonly among men and the third most commontype of malignancy among women. The timely recognition of lung cancer is necessary for decreasing the effect ofdeath rate worldwide. Since the symptoms of lung cancer are identified only at an advanced stage, it is essential topredict the disease at its earlier stage using any medical imaging techniques. This work aims to propose a classificationmethodology for lung cancer automatically at the initial stage.

Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization.

Identifying new predictive biomarkers in lung cancer that will prolong survival for additional subgroups of patients is of utmost importance. We report response to treatment and survival among homologous recombination deficient (HRD) lung cancer patients mostly BRCA mutation carriers to better define the predictive value of HRD status among non-small cell lung cancer (NSCLC).

Iron and Lung Cancer.

Iron is an essential trace element in the human body, and its deficiency or excess induces diverse biological processes. Iron dysregulation is closely associated with the initiation and development of several malignant tumors, including lung cancer. Emerging evidence suggests a particularly important role for iron in lung cancer. Moreover, iron plays a prominent part in multiple forms of cell death, making it important for the development of potential strategies for lung cancer therapy. Here we review the f...

COPD and lung cancer incidence in the Women's Health Initiative Observational Study: A brief report.

Lung cancer is the leading cause of cancer mortality in both men and women in the United States. COPD is associated with lung cancer independently of cigarette smoking, but remains understudied in women. Utilizing data from the Women's Health Initiative Observational Study (WHI-OS), this report investigates the association between COPD and development of lung cancer, with a focus on ethnicity and cancer subtype.

Lung Cancer Incidence in Nonmetropolitan and Metropolitan Counties - United States, 2007-2016.

Lung and bronchus (lung) cancer is the leading cause of cancer death in the United States (1). In 2016, 148,869 lung cancer deaths were reported.* Most lung cancers can be attributed to modifiable exposures, such as tobacco use, secondhand smoke, radon, and asbestos (1). Exposure to lung cancer risk factors vary over time and by characteristics such as sex, age, and nonmetropolitan or metropolitan residence that might affect lung cancer rates (1,2). A recent report found that lung cancer incidence rates wer...


Quick Search